title: The Role of Omalizumab in Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Comment on the Article by Jachiet et al.
authors.affiliation: University of Naples Federico II.
authors.forename: Aikaterini
authors.initials: A
authors.lastname: Detoraki
authors.affiliation: University of Naples Federico II.
authors.forename: Gilda
authors.initials: G
authors.lastname: Varricchi
authors.affiliation: University of Naples Federico II.
authors.forename: Arturo
authors.initials: A
authors.lastname: Genovese
authors.affiliation: University of Naples Federico II and CNR Institute of Experimental Endocrinology and Oncology G. Salvatore.
authors.forename: Gianni
authors.initials: G
authors.lastname: Marone
authors.affiliation: University of Naples Federico II, Naples, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Spadaro
mesh_terms: D000888:Antibodies, Anti-Idiotypic; D015267:Churg-Strauss Syndrome / Q000276:immunology*; D014890:Granulomatosis with Polyangiitis; D006801:Humans; D000069444:Omalizumab; D012008:Recurrence
chemical_list: D000888:Antibodies, Anti-Idiotypic; C026408:anti-IgE antibodies; D000069444:Omalizumab